Intensive Blood Pressure Treatment Goals: Evidence for Cardiovascular Protection From Observational Studies and

Paul K Whelton1,2, Joshua D Bundy1, Robert M Carey3

  • 1Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana, USA.

Insights

Lowering systolic blood pressure (SBP) intensively reduces cardiovascular disease (CVD) events and mortality. Intensive SBP treatment benefits high-risk individuals, including older adults and those with diabetes or kidney disease.

Area of Science:

  • Cardiology
  • Public Health
  • Gerontology

Background:

  • Epidemiologic studies show a direct relationship between blood pressure (BP) and cardiovascular disease (CVD) events.
  • Clinical trials indicate that intensive antihypertensive drug treatment is more effective in preventing CVD than less intensive approaches.

Approach:

  • Meta-analyses of randomized controlled trials support intensive antihypertensive therapy, particularly for systolic blood pressure (SBP) targets of 130 mm Hg or even 120-124 mm Hg.
  • The Systolic Blood Pressure Intervention Trial (SPRINT) compared intensive SBP goals (<120 mm Hg) with standard goals (<140 mm Hg) in high-risk individuals.

Key Points:

  • Intensive SBP treatment (<120 mm Hg) significantly reduced CVD events and all-cause mortality in the SPRINT trial.
  • Benefits were observed across subgroups, including older adults (≥65 years) and those with diabetes or chronic kidney disease.
  • Intensive treatment also led to a lower incidence of cognitive impairment.

Conclusions:

  • Current guidelines often recommend an SBP target of <130 mm Hg for high-risk adults.
  • Intensive SBP management, potentially below 120 mm Hg, offers significant benefits for CVD prevention and mortality reduction in diverse high-risk populations.

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
90
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
67
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
57
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.2K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
54
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
122